|
Reachout's Newsmaker
Dr.Anji Reddy,
Chairman, Dr Reddy's Laboratories Forbes
features him on its cover as the 'Face of the new Indian Pharmaceutical
Industry'
|
|
|
Dr.Kallam
Anji Reddy,58, the founder Chairman of Dr.
Reddy's Group of Companies and a pioneer &
leader in Bulk Drugs and Pharmaceutical Industry
in India has been featured by Forbes Global magazine
on its cover of December 12 issue, calling him the
'Face of the new Indian Pharmaceutical Industry'
Dr. Reddy has done his B.Sc from Andhra Christian
College, Guntur and has completed his B.Sc. (Tech)
in Pharmaceutical Science from Bombay University
and Ph.D. from National Chemical Laboratory, Pune.
Dr. Reddy had six years experience in "Indian
Drugs & Pharmaceuticals Ltd." (IDPL) in
the manufacture and implementation of new
technologies in bulk drugs. After coming out from
IDPL in 1973, Dr.Reddy pioneered a number of bulk
drugs for the first time in the country. The
consumption of many front-line basic drugs has
gone up several folds because of the successful
indigenous development of technologies by his
group of companies. Before starting his own group
of companies, Dr. Reddy has pioneered the
development and production of Metronidazole (1976
MD-Uniloids) and Sulphamethoxazole (1981
MD-Standard Organics Ltd). |
In
1984, he set up Dr. Reddy's Laboratories Ltd and
Cheminor Drugs Limited. Starting with a modest
turnover of Rs.1.5 crore in 1985, the group
registered a combined turnover of Rs.984 crore in
the year 2000-2001.
His mission is clear as stated in one of his many
lectures.' The Patent Act 1970 has enabled the
industry to introduce newer and better medicines
in the country without going through heavy
investments in Research and Development. This
opportunity must be utilized by the industry not
to make enormous profits for themselves; but to
bring these drugs to the masses of India at
affordable prices". |
 |
Dr.Reddy's
Research Foundation (DRF), established in 1992, the
research arm of Dr.Reddy's Group is the first organization
in Indian Pharmaceutical Industry to take up basic
research. Since its inception, DRF has filed a total of 61
patents with the USPTO and 42 with the PCT, for its
discoveries in Cancer, Diabetes, Ulcer and Bacterial
infections. It has been granted 21 patents by the USPTO so
far.
Dr. Reddy's Laboratories has licensed two of its
discoveries in the anti-diabetes field for co-development
to Novo Nordisk of Denmark, a world leader in diabetic
care, in return for an upfront payment, milestone payments
and royalties. Dr. Reddy's has recently out-licensed DRF
4158, an insulin sensitiser in type 2 diabetes, in return
for up to US $ 55 million in upfront and milestone
payments for specific clinical and regulatory endpoints,
as well as royalties. Dr. Reddy's also enjoys the
distinction of being the first Asia Pacific (non-Japanese)
pharmaceutical company to list on NYSE.
These achievements of Dr. Anji Reddy and his group have
been recognized by the Government. Dr.Reddy has been a
member of Drug Technical Advisory Board and Pharmaceutical
Council of India. Dr.Reddy has also served as Chairman of
Andhra Pradesh Industrial Development Corporation (A.P.I.D.C.).
Dr.Reddy had been the President of Indian Pharmaceutical
Congress Association, 1992. Dr. Reddy is a Member of the
Board of Trade. He is the Chairman of FICCI (R&D)
Committee. Dr. Reddy was recently nominated as Member of
the Task Force on Pharmaceuticals and Knowledge-based
industries by the Prime Minister. |
|
Dr. Reddy
had led a delegation of CHEMEXCIL, sponsored by Government
of India, to study the export opportunities, to Europe,
USA and Japan and submitted a report in 1985.
Dr.Reddy has given Key Note addresses in various
pharmaceutical meets at different places like Madras,
Bombay, Calcutta and Presidential Address at IPCA,
Bangalore. These lectures contain a wealth of information
and are considered to be reference papers for many bulk
drug manufacturers.
Dr.Reddy has been encouraging cultural and educational
programs in the State by donating to and sponsoring such
programs from time to time. Critically aware of his own
responsibility to society, he established Dr. Reddy's
Foundation for Human and Social Development to act as a
catalyst in the management of change. Through this social
responsibility of business programme, the first of its
kind in Andhra Pradesh, Dr. Reddy has promoted investments
in entrepreneurship development through micro-finance and
touched the lives of thousands of rural women and their
families and hundreds of street children in the twin
cities of Hyderabad and Secunderabad.
|
Dr.Reddy
has received several awards. Some of the notable
awards are:
SIR P C RAY
AWARD (TWICE) - by Indian Chemical
Manufacturers' Association for development of
indigenous technology (1984 & 1992).
INDIAN CHEMICAL MANUFACTURERS' ASSOCIATION'S
EXPORT AWARD for successfully penetrating the
international market with a sophisticated drug
like Methyldopa (1986)
MANAGER OF THE YEAR 1987 - by Hyderabad
Management Association for outstanding managerial
achievements and contributions made to the
Society.
PROF. NAYUDAMMA MEMORIAL GOLD MEDAL AWARD -
for being the Outstanding Technologist of Andhra
Pradesh for the year 1989 given by A.P. Academy of
Sciences.
LIFE-TIME ACHIEVEMENT AWARD - for Research
and Industry, conferred by ANACON (Indian
Analytical Instrument Association) for the year
1997.
FAPA-ISHIDATE AWARD - given to an
outstanding Asian Pharmacist excelling in
Pharmaceutical Research by the Federation of Asian
Pharmaceutical Associations (FAPA) in the year
1998.
PRAGNA PURASKAR - 1998 Annual Award given
by Pragna Bharati (Andhra Pradesh) for his
outstanding national contribution to the field of
Pharmaceutical R&D.
ACHIEVER OF THE YEAR AWARD - from CHEMTECH
Foundation in November 2000 for his outstanding
contribution to the nation for pioneering the
introduction of affordable medicines to the people
of India.
PADMASHREE AWARD - In March, 2001 by the
President of India for his distinguished service
in the field of Trade and Economic
Activity/Industry. |
Reachout's
Previous Profile on Dr. Anji Reddy
-Maju
Kuriakose
Reachout's News Bureau
|
More Newsmakers..
|
|
